ROSA CORDOVA-LOPEZ: Open Payments
NPI 1760018014 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,636 in 65 payments from 15 companies in 2025. Trend: 2023 $1,904 · 2024 $1,877 · 2025 $1,636
Food & beverage: $1,636
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 6 | $277 |
| Novartis Pharmaceuticals Corporation | 13 | $262 |
| Amgen Inc. | 8 | $243 |
| AstraZeneca Pharmaceuticals LP | 5 | $205 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $137 |
| Merck Sharp & Dohme LLC | 5 | $102 |
| Novo Nordisk Inc | 5 | $97 |
| Boston Scientific Corporation | 3 | $76 |
| Medtronic, Inc. | 2 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
Products named: Attruby, LEQVIO, REPATHA, WAINUA, JARDIANCE, VERQUVO, Wegovy, VENASEAL.
Industry payments across TX — which companies pay providers there.
